VEEV: A Closer Look at Veeva Systems Inc.
ByAinvest
Thursday, Nov 13, 2025 10:24 am ET1min read
VEEV--
Veeva Systems (VEEV) has returned 3.3% over the past month, compared to the Zacks S&P 500 composite's 4.6% change. The Zacks Medical Info Systems industry has lost 6.6% over this period. The company is expected to post earnings of $1.95 per share for the current quarter, a year-over-year change of +11.4%. The consensus earnings estimate of $7.78 for the current fiscal year indicates a year-over-year change of +17.9%. Veeva is rated Zacks Rank #2 (Buy) due to the size of the recent change in the consensus estimate.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet